Polynucleotides for use tags and tag complements, manufacture and use thereof

• US 20070244310A1
• Filed: 03/28/2007
• Published: 10/18/2007
• Est. Priority Date: 01/25/2001
• Status: Active Grant

• Current Assignee: Luminex Molecular Diagnostics Incorporated (DiaSorin S.p.A.)
• Original Assignee: Luminex Molecular Diagnostics Incorporated (DiaSorin S.p.A.)
• Inventors: Janota, Vit, Kobler, Daniel, Pancoska, Petr, Fieldhouse, Daniel, Riccelli, Peter, Benight, Albert, Bullock, Richard
• Granted Patent: US 7,608,398 B2
• Time in Patent Office: Days
• US Class Current: 536/23.100
• CPC Class Codes: C12Q 1/6855 Ligating adaptors
• CPC Class Codes: C12Q 1/6876 Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
• CPC Class Codes: Y10T 436/13 Tracers or tags
• CPC Class Codes: Y10T 436/143333 Saccharide [e.g., DNA, etc.]

Abstract

A family of minimally cross-hybridizing nucleotide sequences, methods of use, etc. A specific family of 210 24mers is described.

Claims

1-106. -106. (canceled)

107. An oligonucleotide tag or tag complement for use in a multiplex assay, wherein the tag or tag complement is selected from the group of oligonucleotides consisting of:

108. The oligonucleotide of claim 107, wherein one of the oligonucleotides in SEQ ID NO. 21, 23-25, 28, 31, 33-34, 37, and 39 does not cross-hybridize with a second, different oligonucleotide in SEQ ID NO. 21, 23-25, 28, 31, 33-34, 37, and 39 under the following hybridization conditions:

0.2 M NaCl, 0.1 M Tris, 0.08% Triton X-100, pH 8.0 at 37°

C.

109. The oligonucleotide of claim 107, wherein the oligonucleotide is attached to a solid support.

110. The oligonucleotide of claim 109, wherein the solid support is a microparticle.

129. An improved method of analyzing a biological sample suspected of comprising a target, wherein the improvement comprises using the oligonucleotide tag or tag complement of claim 107.

111. A nucleic acid tag or tag complement comprising an oligonucleotide selected from the group of oligonucleotides consisting of:

SEQ ID NO;

21, SEQ ID NO;

23, SEQ ID NO;

24, SEQ ID NO;

25, SEQ ID NO;

28, SEQ ID NO;

31, SEQ ID NO;

33, SEQ ID NO;

34, SEQ ID NO;

37 and SEQ ID NO;

39, or a sequence complementary thereto, wherein the oligonucleotide is attached to a solid support.

112. The nucleic acid of claim 111, wherein the solid support is a microparticle.

113. The nucleic acid of claim 111, wherein the oligonucleotide has the sequence set forth in SEQ ID NO.:

21 or the sequence complementary thereto.

114. The nucleic acid of claim 111, wherein the oligonucleotide has the sequence set forth in SEQ ID NO.:

23 or a sequence complementary thereto.

115. The nucleic acid of claim 111, wherein the oligonucleotide has the sequence set forth in SEQ ID NO.:

24 or a sequence complementary thereto.

116. The nucleic acid of claim 111, wherein the oligonucleotide has the sequence set forth in SEQ ID NO.:

25 or a sequence complementary thereto.

117. The nucleic acid of claim 111, wherein the oligonucleotide has the sequence set forth in SEQ ID NO.:

28 or a sequence complementary thereto.

118. The nucleic acid of claim 111, wherein the oligonucleotide has the sequence set forth in SEQ ID NO.:

31 or a sequence complementary thereto.

119. The nucleic acid of claim 111, wherein the oligonucleotide has the sequence set forth in SEQ ID NO.:

33 or a sequence complementary thereto.

120. The nucleic acid of claim 111, wherein the oligonucleotide has the sequence set forth in SEQ ID NO.:

34 or a sequence complementary thereto.

121. The nucleic acid of claim 111, wherein the oligonucleotide has the sequence set forth in SEQ ID NO.:

37 or a sequence complementary thereto.

122. The nucleic acid of claim 111, wherein the oligonucleotide has the sequence set forth in SEQ ID NO:

39 or a sequence complementary thereto.

130. An improved method of analyzing a biological sample suspected of comprising a target, wherein the improvement comprises using the tag or tag complement of claim 111.

131. A kit for sorting and identifying polynucleotides, the kit comprising at least one oligonucleotide tag or tag complement of claim 111.

132. The kit of claim 131, wherein each different oligonucleotide is linked to a defined location on the solid support, the defined location for each said oligonucleotide being different and distinguishable from the defined location for each different oligonucleotide.

133. The kit of claim 132, wherein the solid support is a microparticle.

134. The kit of claim 133, wherein each different oligonucleotide is linked to a different microparticle, each microparticle being distinguishable from each other microparticle.

123. A combination of oligonucleotide tags or tag complements for use in a multiplexed assay comprising at least one oligonucleotide set forth in SEQ ID NOs.:

21, 23-25, 28, 31, 33-34, 37 or 39 and an oligonucleotide selected from the group consisting of SEQ ID NOs.;

1-210, wherein the combination comprises at least two different oligonucleotides set forth in SEQ ID NOs.;

1-210.

124. The combination of claim 123, wherein the oligonucleotides are linked to a solid support.

125. The combination of claim 124, wherein each different oligonucleotide is linked to a defined location on the solid support, the defined location for each said oligonucleotide being different than and distinguishable from the defined location for each different oligonucleotide.

126. The combination of claim 124, wherein the solid support is a microparticle.

127. The combination of claim 126, wherein each different oligonucleotide is linked to a different microparticle, each microparticle being distinguishable from each other microparticle.

128. A combination comprising a plurality of oligonucleotide tags or tag complements for use in a multiplexed assay, wherein the plurality of tags or tag complements include SEQ ID NOs:

21, 23-25, 28, 31, 33-34, 37 and 39 and sequences complementary thereto.